Mounjaro Kwik Tirzepatide Injections

• Mounjaro 7.5mg KwikPen is a once-weekly prescription injection used to help manage blood sugar levels in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that belongs to a newer class of medicines called incretin mimetics. This medication helps improve blood sugar levels when diet and exercise alone are not enough.
• Mounjaro is intended for use when lifestyle measures such as diet and exercise alone do not adequately control blood glucose. The KwikPen device is a prefilled, multi-dose pen designed for ease of self-administration at home. Each pen contains four fixed doses of the specified strength, meaning a 7.5mg pen holds a total of 30mg of tirzepatide (4 doses x 7.5mg), 0.6 ml each. Patients inject one dose per week, so each pen is designed to last for one month. This convenient dosing schedule helps maintain steady blood levels and simplifies treatment.
• This medication is specifically indicated for type 2 diabetes and should not be used for type 1 diabetes or diabetic ketoacidosis. Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) must avoid this treatment. Always use Mounjaro under the supervision of a qualified healthcare provider. Mounjaro 7.5 mg in India is available through select pharmacies and online medical suppliers, with prices varying depending on the seller and location.

Mounjaro 7.5mg KwikPen is approved for:

• Improving blood sugar control in adults with type 2 diabetes mellitus

• Used in combination with diet and exercise

• May be used alone or with other diabetes medications